WHO-GMP/GMP Partner Network

Searching for a
Better Health Resolution?

First, welcome to Sehwin Healthcare. We provide the best health answers. Specifically, we offer great medicine. As a result, we focus on quality, safety, and your health worldwide.

Sehwin Healthcare Advanced Pharmaceutical Manufacturing Facility in Ambala
5+
Years of
Excellence in Pharma

Quick Composition Finder

Search our 150+ formulations by molecule name (e.g. Mecobalamin, Aceclofenac)

WHO GMP Certified
Best Quality Items
DCGI Approved
FSSAI Approved
Strict Quality Control
100% Safe Medicines
Trusted by Doctors
PAN India Delivery
WHO GMP Certified
Best Quality Items
DCGI Approved
FSSAI Approved
Strict Quality Control
100% Safe Medicines
Trusted by Doctors
PAN India Delivery

150+

Pharmaceutical Products

20+

States Served

100%

Quality Guarantee

500+

Trusted Partners

Sehwin Healthcare Quality Pharmaceutical Tablets and Capsules Portfolio

About Our Company

A Quickly Expanding Pharmaceutical Company

Currently, Sehwin is growing fast. Truly, this is due to our strong team spirit. We always ensure good quality. For example, we use approved WHO and GMP-certified partner factories. Consequently, we meet the highest global standards.

  • New Ideas & Testing
  • Trusted Factory Network
  • Large Delivery Network
  • Honest Business Rules
Read Our Full Story

Our Catalog

Featured Pharmaceutical Products

First, discover a selection of our top medicines. Additionally, these are our most trusted items. Furthermore, they work very well.

Our Capabilities

Why Choose Sehwin?

First, we combine smart science with high quality. Therefore, we deliver highly effective answers. Ultimately, your success is our main priority.

Focus on Quality

First, we check all raw materials. Then, we test all finished products. Thus, we ensure total quality.

New Ideas

We always seek better formulas. As a result, we solve modern health issues well.

Patient First

First, your safety is our goal. Therefore, every choice we make helps the patient.

Proven Results

Our medicines work very well. Consequently, doctors all over trust our brand.

Testimonials

What Our Partners Say

Trusted by healthcare professionals and distributors worldwide.

"First, their focus on quality is amazing. Also, their items are very reliable. As a result, we have trusted them for years."

RP

M/s Rajesh Pharma

Medical Distributor

"Firstly, the results of their medicines are great. We see amazing patient outcomes. Therefore, I highly recommend them."

SS

Dr. Sneha Sharma

Clinical Director

"First, they run a highly honest business. Also, they have a reliable factory network. In short, Sehwin is the perfect partner."

AP

Mr. Amit Patel

Regional Partner

F.A.Q

Frequently Asked Questions

First, find answers to common questions here. Specifically, you can learn about our products. Additionally, we cover our franchise model and manufacturing details.

What help do you give to your franchise partners?

First, we offer great marketing help. For example, we give you visual aids, cards, and bags. Also, we help you promote our items easily.

Are your medicines DCGI approved and WHO-GMP certified?

Yes, our medicines are made in approved WHO-GMP factories. Also, they follow DCGI rules. As a result, they are safe and work well.

How can I get PCD Pharma rights in my area?

First, you can apply for rights in your region. Just contact our sales team. In short, we welcome new partners across India.

What types of medicines does Sehwin cover?

Firstly, we offer a wide range of general and special medicines. These include antibiotics, painkillers, and vitamins. As a result, you get tablets, syrups, and more.

Do you offer fast delivery and always have stock?

Yes, absolutely. We keep a strong supply chain. Therefore, we ensure no stock-outs. Consequently, you can serve patients without any delay.

Ready to Boost Your Supply?

Finally, partner with Sehwin Healthcare today. As a result, you will get reliable, high-quality products. Furthermore, you will receive great service.

Contact Our Sales Team

First published: January 1, 2024 | Last updated: May 18, 2026